Mycovia Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Mycovia Pharmaceuticals Ownership

Who owns Mycovia Pharmaceuticals?

Mycovia Pharmaceuticals is owned by NovaQuest. It was acquired on January 3, 2018.

Is Mycovia Pharmaceuticals PE-backed?

Yes. Mycovia Pharmaceuticals is owned by private equity investor NovaQuest.

Mycovia Pharmaceuticals Business Overview

Where is Mycovia Pharmaceuticals headquartered?

Mycovia Pharmaceuticals is headquartered in Durham, North Carolina.

What sector is Mycovia Pharmaceuticals in?

Mycovia Pharmaceuticals is a life science company.

When was Mycovia Pharmaceuticals founded?

Mycovia Pharmaceuticals was founded in 2018.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 247 acquisitions of life science companies in 2018, including 45 acquisitions by private equity firms, and 202 by strategics.

Mycovia Pharmaceuticals

Mycovia Pharmaceuticals, Inc.

4505 Emperor Boulevard Suite 300,
Durham, North Carolina 27703
United States,
(919) 467-8539
www.mycovia.com

Mycovia Pharmaceuticals is a biopharmaceutical company that embodies the community’s commitment to innovation in the life sciences. We believe in treatment equality and supporting those who suffer from medical conditions that have not been addressed adequately. Mycovia Pharmaceuticals was founded in 2018 and is based in Durham, North Carolina.


 Subscribe to unlock this and 202,225
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.